VACCINE COMPOSITIONS FOR PROTECTING AGAINST VISCERAL LEISHMANIASIS, SYNTHETIC PEPTIDES AND USES

The present technology relates to vaccine compositions for the treatment and/or prevention of visceral leishmaniasis in mammals, comprising six synthetic peptides that are free or expressed in the surface of non-infectious bacteriophages selected by means of a proteomic phase display approach for us...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FERRAZ COELHO, Eduardo Antônio, MENEZES SOUZA, Daniel, COSTA DUARTE, Mariana, SILVEIRA SALLES, Beatriz Cristina, EMANUELE COSTA, Lourena, MENDES ROATT, Bruno, PEREIRA TAVARES, Carlos Alberto
Format:	Patent
Sprache:	eng ; fre ; por
Schlagworte:	CHEMISTRY GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present technology relates to vaccine compositions for the treatment and/or prevention of visceral leishmaniasis in mammals, comprising six synthetic peptides that are free or expressed in the surface of non-infectious bacteriophages selected by means of a proteomic phase display approach for use in isolation or in any possible combinations. La présente technologie concerne des compositions vaccinales pour le traitement et/ou la prévention de la leishmaniose viscérale chez des mammifères, comprenant six peptides synthétiques libres ou exprimés sur la surface de bactériophages non infectieux, choisis au moyen d'une approche protéomique d'exposition sur phage, en vue d'une application isolée ou en combinaisons possibles entre eux. A presente tecnologia trata de composições vacinais para o tratamento e/ou a prevenção da leishmaniose visceral em mamíferos, compreendida por seis peptídeos sintéticos livres ou expressos na superfície de bacteriofagos não infecciosos, que foram selecionados por meio de uma abordagem proteômica de phage display, para serem aplicados isoladamente ou em possíveis combinações entre os mesmos.